SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000947871-11-000671
Filing Date
2011-07-29
Accepted
2011-07-29 12:50:17
Documents
4
Group Members
DOMINIQUE SEMONMERLIN BIOMED PRIVATE EQUITY ADVISORS, LLCMERLIN NEXUS III, L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ss124578_sc13d-icagen.htm SC 13D 116153
2 JOINT LETTER ss124578_ex9901.htm EX-99.1 18789
3 PRESS RELEASE ss124578_ex9902.htm EX-99.2 13018
4 JOINT FILING AGREEMENT ss124578_ex9903.htm EX-99.3 9996
  Complete submission text file 0000947871-11-000671.txt   159387
Mailing Address
Business Address 4222 EMPEROR BLVD SUITE 350 DURHAM NC 27703 919-941-5206
ICAGEN INC (Subject) CIK: 0000902622 (see all company filings)

IRS No.: 561785001 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-81358 | Film No.: 11996545
SIC: 2834 Pharmaceutical Preparations

Mailing Address 230 PARK AVE, SUITE 928 NEW YORK NY 10169
Business Address 230 PARK AVE, SUITE 928 NEW YORK NY 10169 646-227-5270
Merlin BioMed Private Equity Advisors, L.L.C. (Filed by) CIK: 0001429303 (see all company filings)

IRS No.: 000000000
Type: SC 13D